HOME >> BIOLOGY >> NEWS
ORNL nanoprobe creates world of new possibilities

OAK RIDGE, Tenn., July 14, 2004 -- A technology with proven environmental, forensics and medical applications has received a shot in the arm because of an invention by researchers at the Department of Energy's Oak Ridge National Laboratory.

ORNL's nanoprobe, which is based on a light scattering technique, can detect and analyze chemicals, explosives, drugs and more at a theoretical single-molecule level. This capability makes it far more selective and accurate than conventional competing technologies.

The probe is an optical fiber tapered to a tip measuring 100 nanometers with an extremely thin coating of nanoparticles of silver, which induces the surface-enhanced Raman scattering (SERS) effect. Normally, when a sample is illuminated by a laser beam, there is a small reflection of light, known as Raman scattering. The light shows vibration energies, which are unique to each compound, and that information allows scientists to identify the substance.

With the SERS nanoprobe, the laser light creates rapid oscillations of the electrons in the silver nanoparticles, which produce an enormous electromagnetic field that contributes to increase the Raman scattering signal. The ORNL nanoprobe works with any surface to induce the SERS effect.

"The significance of this work is that we are now able to perform direct analysis of samples -- even dry samples -- with no preparation of the surface," said ORNL's Tuan Vo-Dinh, who leads a team that developed the nanoprobe. "Also, the small scale of the nanoprobe demonstrates the potential for detection in nanoscale environments, such as at the intracellular level."

Ordinarily, surface-enhanced Raman scattering analysis of samples on a surface requires modification or treatment of the sample. This may consist of physically removing the sample and diluting it in a liquid containing silver nanoparticles; however, this practice is unnecessary with the ORNL nanoprobe.

Vo-Dinh and Life Sciences
'"/>

Contact: Ron Walli
wallira@ornl.gov
865-576-0226
DOE/Oak Ridge National Laboratory
14-Jul-2004


Page: 1 2

Related biology news :

1. Electrodes and nanoprobes signal new DNA detection method
2. UAB creates the first Internet server to search for genetic diversity
3. Scientists discover how anthrax creates its deadly spores
4. Ohio State creates first gene chip for horse
5. Philippines: Park expansion creates nations largest contiguous protected area
6. Packard Childrens Hospital gift creates new biotech research center for childrens health
7. Laboratory theme park re-creates RNA world for study
8. Gene loss creates age- and gender-dependent cancer syndrome in mice
9. Gift creates KSU Human Origins Study Institute
10. Purdue creates self-generating nanotubes with dial-up properties
11. Razing old dams solves some problems, creates new ones

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ORNL nanoprobe creates world new possibilities

(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: